Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Debt Ratio (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Debt Ratio for 14 consecutive years, with 0.05 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 62.15% to 0.05 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05 through Dec 2025, down 62.15% year-over-year, with the annual reading at 0.05 for FY2025, 62.15% down from the prior year.
  • Debt Ratio hit 0.05 in Q4 2025 for Guided Therapeutics, down from 0.12 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.95 in Q2 2024 to a low of 0.01 in Q3 2022.
  • Historically, Debt Ratio has averaged 0.24 across 4 years, with a median of 0.11 in 2025.
  • Biggest five-year swings in Debt Ratio: tumbled 98.64% in 2021 and later soared 1160.02% in 2022.
  • Year by year, Debt Ratio stood at 0.05 in 2021, then plummeted by 44.9% to 0.03 in 2022, then soared by 303.04% to 0.12 in 2024, then plummeted by 62.15% to 0.05 in 2025.
  • Business Quant data shows Debt Ratio for GTHP at 0.05 in Q4 2025, 0.12 in Q3 2025, and 0.1 in Q2 2025.